https://www.einpresswire.com/article/913871100/abl-diagnostics-drives-emea-expansion-with-vela-diagnostics-partnership
ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership Read More »
https://www.abldiagnostics.com/wp-content/uploads/2026/05/P190.pdf
https://www.einpresswire.com/article/913010661/abl-diagnostics-unveils-next-generation-hiv-genotyping-innovation-with-the-industry-s-broadest-portfolio
https://www.einpresswire.com/article/912523931/abl-diagnostics-announces-strategic-ai-roadmap-to-advance-molecular-research-and-global-data-security
Official Presentation of the DeepChek® HPV Messenger RNA Genotyping Assay Webinar from June 26, 11h00 CET / Paris time https://ablsa-my.sharepoint.com/:f:/p/matthieu_barralon/EoLXon5w0g9AhQlr5kZTO_gBQ9TVE9AcQJuJu_Cw_9Y1Jw?e=OU2KLh
ABL Diagnostics Webinar Series Read More »
Julia Faillace Thiesen , Elise Jacquemet , Pascal Campagne, Denis Chatelain, Etienne Brochot, Yves‑Edouard Herpe , Nolwenn M. Dheilly , Fabrice Bouilloux, Bénédicte Rognon, Alexandre Douablin, Guillaume Leboucher , Florent Percher, Marc Eloit and Philippe Pérot Abstract Background Cervical cancer screening programs are increasingly relying on sensitive molecular approaches as primary tests to detect high‑risk
ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co., Ltd. (https://www.rikengenesis.jp/en.html). Under this partnership, Riken Genesis will promote and commercialize ABLD’s DeepChek® and UltraGene molecular assays across laboratories in Japan, further strengthening its diagnostics portfolio. Through this collaboration, Riken Genesis
REAL LIFE EXPERIENCE: The relevance of ultradeep sequencing for low HIV‐1 viral loads and proviruses in the clinical setting Webinar from Tuesday November 19, 2024 – 4pm CEST https://ablsa-my.sharepoint.com/:f:/p/matthieu_barralon/EoLXon5w0g9AhQlr5kZTO_gBQ9TVE9AcQJuJu_Cw_9Y1Jw?e=OU2KLh
ABL Diagnostics Webinar Series Read More »
NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ — AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, is pleased to announce today the execution of a co-marketing agreement to co-promote in the USA Next Generation
The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in the clinical setting Alizée Foury 1 2, Aline Saunier 2, Audrey Taverniers 2, Nathalie Pinet 2, Thomas Josse 2, Eliette Jeanmaire 3, Caroline Emilie 3, Evelyne Schvoerer 2 4, Cédric Hartard 2 4 Abstract Improving the therapeutic management of HIV-positive persons is a major public health issue and includes better detection of drug resistance mutations (DRMs). The aim of this study was
https://pubmed.ncbi.nlm.nih.gov/39185639/ Read More »
